Abstract
Background Maternal mortality ratio (MMR) declined in Pakistan from 276 maternal deaths per 100,000 live births in 2006-07 to 186 (confidence interval: 138-234) in 2019. Despite this decline, reasons why mothers continue to die, the inequity in the burden of maternal mortality and its predictors largely remain unknown. We investigate the levels and predictors of maternal mortality in Pakistan.
Methods The in-depth analysis of Pakistan Maternal Mortality Survey (PMMS) 2019 was undertaken using the nested case-control design. We matched 147 maternal deaths that occurred during three years prior to PMMS 2019, defined as “cases”, with 724 women who delivered during the same period, defined as “controls”. We compared socio-demographic background characteristics of cases and controls and performed multivariate regression to investigate the predictors of maternal mortality in Pakistan.
Results Cases and controls were similar on access to antenatal care (ANC) and ANC provider, but differed on age, education, number of pregnancies, type of delivery, tetanus toxoid vaccination during last pregnancy, and ever using a contraceptive method. More of the cases had their last delivery by a skilled birth attendant (83% compared to 63% among controls) and delivered at the government hospital (43% compared to 33% among controls) while home delivery was relatively more common among controls (32% compared to 25% among cases). Odds of maternal death were lowest for women giving birth during age 20-29 (odds ratio – OR: 0.5; 95% CI 0.23-1.07) as compared to women in age 15-19 and those age 30-39 (OR: 1.34; 95% CI 0.61-2.95) and 40-49 (OR: 1.21; 95% CI 0.42-3.45), and among women with secondary or higher education (OR: 0.35; 95% CI 0.17-0.74) compared to women with no education. Surprisingly, women who had their delivery by a skilled birth attendant experienced higher odds of maternal death (OR: 4.07; 95% CI 2.19- 7.57) compared to those who did not. Whereas women having had tetanus injection during last pregnancy (OR: 0.1; 95% CI 0.0-0.96) and ever-used contraceptives (OR: 0.23; 95% CI 0.11-0.39) tend to have reduced odds of maternal death compared to women who did not have the injection and who never used contraceptives, respectively.
Conclusions Women in certain sub-groups confront higher risks of maternal death. Increasing female education, preventing early and late childbearing through contraceptive use, increasing tetanus vaccination during pregnancy, improving providers’ skills, and quality of health care are required to eliminate preventable maternal deaths in Pakistan.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The manuscript is based on secondary analysis of open access datasets of national surveys of Pakistan namely the Pakistan Demographic Health Survey, and Pakistan Maternal Mortality Survey and hence do not warrant IRB approvals
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying the results presented in the study are available from https://dhsprogram.com/data/available-datasets.cfm
